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and results will be discussed. The implications of these studies for
immune responses andvaccinedevelopmentwill alsobediscussed.
http://dx.doi.org/10.1016/j.ijid.2012.05.15060 15th ICID Abstracts / International Journ
ependent on the interferon regulatory factors, IRF3/7, the IKK-
elated kinase TBK1 and the ER-resident protein STING. However,
reviously described cytosolic nucleic acid sensors RIG-I, MDA-5,
AVS, RNA Polymerase III, DAI and Nod2 are not required. We also
how that hemozoin bound AT-rich DNA gains access to the cytosol
uring phagocytosis by macrophages.
We demonstrate for the ﬁrst time that Type I IFN responses are
ey in regulating the progression of malarial infections. Microar-
ay analysis of patient samples identiﬁed type I IFN induced genes
ISGs) as signiﬁcantlyupregulated inhumanpatients infectedwith-
lasmodium falciparum.Moreover, in a mouse model of cerebral
alaria, mice lacking the IFNa/b Receptor (IFNAR-/-), transcrip-
ion factors IRF3 an IRF7 as well as TANK-binding kinase 1 (TBK1)
n the DNA-sensing pathway and the critical adaptor Stimula-
or of Interferon Genes (STING) are protected from disease. This
tudy therefore highlights the importance of cytosolic DNA sensing
athways in the immune response toPlasmodium falciparumand
rovides critical insight into the mechanisms by which the early
nnate immune response determines the end-stage of malarial dis-
ase.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.148
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Tuberculosis (TB) is a major health problem with 10 million
ew cases diagnosed each year, causing nearly 2 million deaths.
owever, from the estimated 2 billion individuals initially being
nfected withMycobacterium tuberculosis(Mtb), most develop a
atent infection, where the microbe will survive and persist for
ears inside lung macrophages. Following coinfections or immune
upression, some may develop active disease. Furthermore, only
small fraction of close house-hold contacts to patients with
ctive TB will develop active disease, despite not being vaccinated
gainst or previously exposed to Mtb. These facts suggest that an
ffective early innate immune response is important for immune
urveillance and early protection against Mtb. We have there-
ore investigated the innate immune response and how it can be
oosted during TB. Our hypothesis were (i) that neutrophils, being
ecruited early to the site of infection, can modulate the capacity of
acrophages to handle Mtb, and (ii) that the production of nitric
xide (NO) may play a vital role, since Mtb is usually very sensi-
ive to reactive nitric intermediates (RNI). In different experimental
odels we show that Mtb-infected apoptotic neutrophils enhance
he proinﬂammatory cytokine response in human macrophages,
nd improve their capacity to control infection with virulent Mtb.
his activation is triggered through release of heat-chock protein
2 (Hsp72) and formation of neutrophil extracellular traps (NETs),
nd mediated via Toll- and NOD-like receptors. In clinical studies
e furthermore show that that boosting the NO production with
rginine or arginine-rich supplement to patients being treated for
ctive TB, will improve treatment and reduce potential spreading
f the disease. The important role of NO is furthermore supportednfectious Diseases 16S (2012) e2–e157
by observations that clinical strains exhibiting reduced susceptibil-
ity to NO may be more detrimental to the host, and that coinfected
(HIV) patients with TB have show reduced production of NO from
the lung.
We can conclude that stimulation of the innate immune
responsemay be important for preimmunemacrophage activation,
and protection against Mtb infection.
http://dx.doi.org/10.1016/j.ijid.2012.05.149
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MHC Class I antigen presentation and implications for vaccine
development
K. Rock
University of Massachusetts Medical School, Worcester, MA, USA
All cells generate peptides derived from their expressed genes
and then display a fraction of them on the cell surface bound to
MHC class I molecules through a process called antigen presen-
tation. This process is important because it is the key pathway
by which the immune system detects and then eliminates viral
infections. Antigen presentation not only controls whether T cell
responses will be generated, but also their magnitude, speciﬁcity
and location. Although this process is essential for host defense, its
underlyingmechanismsare incompletelyunderstood. Themajority
ofMHCclass I presentedpeptides are generated by the proteasome.
Dendritic and many other leukocytes express an alternate form
of the proteasome, called the immunoproteasome, that contains
a distinct set of proteolytic active sites. In an infection, immuno-
proteasomes can be induced in most other cell types. We have
generated mice that completely lack immunoproteasomes and
have characterized their ability to present antigens and respond to
viral infections. These mice have major changes in their repertoire
of MHC class I-presented peptides and defects in antigen presenta-
tion that strongly affect T cell responses to viruses. In other studies
we have been examining the source of MHC class I-presented pep-
tides. It had been proposed that the majority of class I presented
peptides derive fromnewly synthesized but defective proteins.We
have generated experimental systems to critically test this model
